https://doi.org/10.2353/ajpath.2010.100328
S
Seok‐Hyung Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
2.9K
Citations
32
h-index
60
i10-index
Seok‐Hyung Kim is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Cancer Cells and Metastasis & Metastasis and carcinoma case studies & Cancer-related gene regulation. The author has an h-index of 32, co-authored 96 publications.
ORCID: 0000-0001-9028-6919Papers by this author
worksThe Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma
2010 · American Journal Of Pathology · 124 citations
PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression
2022 · Nature Communications · 97 citations
https://doi.org/10.1038/s41467-022-30484-4
Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma
2011 · Head & Neck · 54 citations
https://doi.org/10.1002/hed.21716
DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer
2018 · Cell Death and Disease · 44 citations
https://doi.org/10.1038/s41419-018-0899-9
Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis
2018 · Investigational New Drugs · 22 citations
https://doi.org/10.1007/s10637-017-0547-8
Decreased Expression of the Polarity Regulatory PAR Complex Predicts Poor Prognosis of the Patients with Colorectal Adenocarcinoma
2017 · Translational Oncology · 8 citations
https://doi.org/10.1016/j.tranon.2017.11.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat